Iododoxorubicin

iso certificate
Get a quote
SDS Request
Get a Quick Quote Now
Select Packaging

Get a quote

For more information call
phone_icon
(914) 654-6800
or email
mail_icon
INFO@PARCHEM.COM

For more information

Product Description

Product
Iododoxorubicin
CAS
83997-75-5
Formula
C27H28INO10
Synonym
Iododoxorubicin, 4'-Iodo-4'-deoxydoxorubicin, 4'-Deoxy-4'-iododoxorubicin, 83997-75-5, 65JH75I9JX, (8S,10S)-10-{[(2R,4S,5S,6S)-4-amino-5-iodo-6-methyltetrahydro-2H-pyran-2-yl]oxy}-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione, NSC-378901, FCE 21954, Iodo-Dox, IDX, FCE-21954, I-DOX, WP 154;4'-Iodo-4'-deoxydoxorubicin; FCE 21954, 4-iodo-4-deoxydoxorubicin, UNII-65JH75I9JX, SCHEMBL62735, CHEBI:47897, DTXSID301004258, 5,12-Naphthacenedione, 10-(((2R,4S,5S,6S)-4-aminotetrahydro-5-iodo-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)-, 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-10-((4-aminotetrahydro-5-iodo-6-methyl-2H-pyran-2-yl)oxy)-8-(hydroxyacetyl)-1-methoxy-6,8,11-trihydroxy-, (2R-(2-alpha(8S*,10S*),4-beta,5-beta,6-beta))-, Q27120844, 10-[(4-Amino-5-iodo-6-methyloxan-2-yl)oxy]-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione

Typical Product Specifications

Assay/Purity
Typically NLT 98%
Notes
Iododoxorubicin is  classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate  
Class
Industry
Get a quote
Get a quote
Iododoxorubicin
iso certificate
Get a quote
SDS Request

For more information call
phone_icon
(914) 654-6800
or email
mail_icon
INFO@PARCHEM.COM

For more information

Product Description

Product
Iododoxorubicin
CAS
83997-75-5
Formula
C27H28INO10
Synonym
Iododoxorubicin, 4'-Iodo-4'-deoxydoxorubicin, 4'-Deoxy-4'-iododoxorubicin, 83997-75-5, 65JH75I9JX, (8S,10S)-10-{[(2R,4S,5S,6S)-4-amino-5-iodo-6-methyltetrahydro-2H-pyran-2-yl]oxy}-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione, NSC-378901, FCE 21954, Iodo-Dox, IDX, FCE-21954, I-DOX, WP 154;4'-Iodo-4'-deoxydoxorubicin; FCE 21954, 4-iodo-4-deoxydoxorubicin, UNII-65JH75I9JX, SCHEMBL62735, CHEBI:47897, DTXSID301004258, 5,12-Naphthacenedione, 10-(((2R,4S,5S,6S)-4-aminotetrahydro-5-iodo-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)-, 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-10-((4-aminotetrahydro-5-iodo-6-methyl-2H-pyran-2-yl)oxy)-8-(hydroxyacetyl)-1-methoxy-6,8,11-trihydroxy-, (2R-(2-alpha(8S*,10S*),4-beta,5-beta,6-beta))-, Q27120844, 10-[(4-Amino-5-iodo-6-methyloxan-2-yl)oxy]-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione

Typical Product Specifications

Assay/Purity
Typically NLT 98%
Notes
Iododoxorubicin is  classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate  
Class
Industry
Get a quote
Get a quote